Post by
InvrsContrarian on Jul 27, 2020 12:36pm
Aristotle
What would one pay for a cancer screener that tests for 10 cancers at once? What is fair market value for such a test. Then I beg you to run conservative testing numbers once this covid thingy had passed and then the possibility of royalty rights when they release the test to other labs. Would stage retains the rights or sell it off to Pfizer or some other conglomerate? That's the question I'm contenplating.
Comment by
SAGDollar on Jul 27, 2020 12:59pm
JHT stated more than 1000 USD less than 3000 USD per each Aristotle test. Which is pretty competitive where they can make good profits but not be unaffordable. In regards to Grail their test is in R&D phase still with no clinical validation in addition to a lesser sensitivity and specificity.
Comment by
InvrsContrarian on Jul 27, 2020 1:07pm
My thoughts are sitting in that price range as well. I know someone who had beaten lung cancer because it was detected by chance. Now he would be a good candidate for a flare up and he would want to get tested to find out if the cancer came back. Or if it changed into something else.